Recall Register

Drug recall: Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles (…

Class III FDA enforcement event 77567. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Cross Contamination With Other Product: Imipramine

Class III, in the words of FDA

a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences

Sandoz Incorporated started this drug recall on 16 Jun 2017. The firm address in the FDA record is in Broomfield, CO. FDA put the recall in Class III. FDA event 77567 has 1 product record. The first FDA enforcement report date is 12 Jul 2017. The record gives the status Terminated, with the termination date 14 Jan 2019. 93 of the 343 drug events that started in 2017 have more product records. The median drug event of 2017 has 1 product record. The openFDA file has 343 drug events that started in 2017 and 288 that started in 2016.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Product was distributed throughout the United States

Recalling firm

Sandoz Incorporated, Broomfield, CO.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 77567: product records
Recall numberProductQuantityClassStatusReport date
D-0943-2017Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 0854038,234 bottlesClass IIITerminated12 Jul 2017

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class III: The lowest of the three FDA recall classes.

The event in context

Drug events that started in 2017
343
Share of these events in Class III
30%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
15

Other events of the firm

Other FDA enforcement events of Sandoz Incorporated
InitiatedProduct (first record)TypeClassRecords
6 Apr 2018Triamterene and Hydrochlorothiazide Tablets, USP, 75 mg/50 mg, 500-count bottles, Rx only, Manufactured by Sandoz, Inc.,DrugClass III1
22 Dec 2016Nadolol Tablets, USP, 40mg, packaged in 1000-count bottle, Rx Only, Manufactured by Sandoz Inc., Princeton, NJ 08540, NDDrugClass II1
5 Dec 2014Fluoxetine Capsules USP, 20 mg, 100 count bottle, Rx Only, 100 Capsules, Sandoz Inc Princeton, NJ 08540 NDC 0781-2822-01DrugClass III1
25 Jul 2014Alprazolam Tablets, USP, 0.25mg, Rx only, 1000 tablets, Sandoz Inc., Princeton, NJ --- NDC 0781-1061-10DrugClass II1
22 Oct 2013Tacrolimus Capsules, USP, 0.5 mg, 100 capsules/bottle, Rx only, Manufactured in India by Sandoz Private ltd. for Sandoz DrugClass II1
25 Sep 2013Hydroxychloroquine Sulfate Tablets, USP, 200 mg, Rx Only, 100 Tablets per bottle, Sandoz Inc., Princeton NJ, 08540, NDC DrugClass III1
7 Aug 2013Introvale (levonorgestrel and ethinyl estradiol) tablets, USP, 0.15 mg/0.03 mg, packaged in 91 day regimen per unit cartDrugClass III1
21 Jun 2013Estarylla (Norgestimate and Ethinyl Estradiol) Tablets. USP, 0.25mg/0.035mg, 3X28 tablets per carton. Rx only, ManufactuDrugClass II1
30 May 2013Cefazolin, injection, 1 gram per vial, 25 vials per box, sterile, Rx only, single-use vial, Manufactured in Austria by SDrugClass II1
20 May 2013Methotrexate Injection, USP, Preservative-Free, 1 g/40 mL (25 mg/mL), 40 mL Single Dose Vial, Rx only, Manufactured for:DrugClass I1

Sandoz Incorporated: all 15 events

Official channels

Cite this page

Recall Register. FDA enforcement event 77567. https://recallregister.com/fda/iii/77567/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
10 Nov 2026
Newest FDA report date on the register
4 Nov 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Product was distributed throughout the United States
What quantity of product is in FDA event 77567?
The FDA record gives this quantity: 38,234 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2017 have the same class?
30% of the 343 drug events that started in 2017 are in Class III.